Gene · 6624
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CaMKII generates actin bundle morphology and mechanics distinct from canonical bivalent cross-linkers. | bioRxiv | 2026 | 42817999 | PubTator, text mining | PubMed |
| FSCN1 Modulates Fatty Acid Metabolism and the Coordinated Activation of AKT/mTOR and p38 MAPK Pathways in Colorectal Cancer Cells. | Oncol Res | 2026 | 42769853 | PubTator, text mining | PubMed |
| The RNA-binding protein La/SSB is associated with HNSCC progression and TFAP2C/FSCN1-linked transcriptional regulation. | Oncogene | 2026 | 42693251 | PubTator, text mining | PubMed |
| Fascin-Centred Invasive Competence in Eutopic Endometrium: A Hypothesis-Driven Narrative Review of Endometriosis Pathogenesis and Non-Surgical Biomarker Potential. | Int J Mol Sci | 2026 | 42653239 | PubTator, text mining | PubMed |
| Fascin in dendritic protrusions is required for synaptic plasticity. | J Biol Chem | 2026 | 42617739 | PubTator, text mining | PubMed |
| [Expression of Concern] MicroRNA‑145‑5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells. | Mol Med Rep | 2026 | 42596825 | PubTator, text mining | PubMed |
| State-dependent energy conversion produces degenerate dissipation in active actomyosin networks. | bioRxiv | 2026 | 42395412 | PubTator, text mining | PubMed |
| Synergistic assembly, disassembly, and protection of complex forms of bundled F-actin. | J Cell Biol | 2026 | 42384037 | PubTator, text mining | PubMed |
Integrative multi-omics and single-cell analysis identifies EGFR pathway activation and metabolic reprogramming as potential synthetic lethal vulnerabilities in resistance to the FGFR inhibitor AZD4547. | J Transl Med | 2026 | 42351126 | PubTator, text mining | PubMed |
| Fascin-1 expression in non-small cell lung cancer and its diagnostic implications. | Discov Oncol | 2026 | 42258099 | PubTator, text mining | PubMed |
| circ-FSCN1 affects ferroptosis and cell viability in NSCLC via the miR-506-3p/SLC7A1 pathway. | Transl Oncol | 2026 | 42107319 | PubTator, text mining | PubMed |
| Distinct molecular and tumor microenvironment characteristics of mucinous adenocarcinoma in colorectal cancer. | iScience | 2026 | 42100746 | PubTator, text mining | PubMed |
| Design of Safe and Efficient Adenine Base Editors via Protein Language Model Screening for Osteoarthritis Treatment. | Adv Sci (Weinh) | 2026 | 42052652 | PubTator, text mining | PubMed |
| FSCN1 drives sarcoma progression and immunosuppression revealed by pan-cancer analysis and functional assays. | Discov Oncol | 2026 | 42032380 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis of FSCN1 as a marker for prognosis and immunity. | Discov Oncol | 2026 | 41945244 | PubTator, text mining | PubMed |
| Complex aberrant expression of planar nuclear polarity factors in intraductal papillary mucinous neoplasm of the pancreas. | Virchows Arch | 2026 | 41902867 | PubTator, text mining | PubMed |
| Proangiogenic Properties of Extracellular Vesicles Secreted by Endothelial Cells Reversibly Primed for Anoikis: A Possible Autocrine Mechanism Induced by Astrocytoma Extracellular Matrix. | Int J Mol Sci | 2026 | 41898438 | PubTator, text mining | PubMed |
| A Lactylation-based Gene Signature in Lung Adenocarcinoma Provides a Novel Perspective to Predict the Prognosis and Therapeutic Response. | Curr Med Chem | 2026 | 41837482 | PubTator, text mining | PubMed |
| Divergent roles of circMPP6 and its parental gene MPP6 in non-small cell lung cancer. | Front Cell Dev Biol | 2026 | 41799439 | PubTator, text mining | PubMed |
| Cold exposure and human metabolism: A heterogeneous response across tissues and organs. | Temperature (Austin) | 2026 | 41797814 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6624/papers